**Study Overview:** This study is looking at how safe and effective a drug called cenobamate is for children aged 2-17 who have partial-onset seizures, which are localized seizures affecting part of the brain. The study will also check how the drug moves through the body and how well it's tolerated when taken as tablets or liquid. Researchers will assess if the medication is easy for children to take and if it tastes okay.
**Eligibility:** To join, kids must have epilepsy with partial-onset seizures for at least a year and must weigh at least 22 pounds. They should also have had a brain scan in the last 10 years ruling out progressive epilepsy. Children must be on a stable dose of up to three epilepsy medications for at least four weeks before starting.
**Key Points:**
- Participation involves regular study visits, including assessments on Day 1 and Day 15.
- Participants may continue taking their current epilepsy medications during the study.
- This study can offer new treatment options, but participants must not have certain health conditions or be pregnant.
_Consult with your healthcare provider to understand more about the benefits and risks of participating in this study._
How understandable was the trial content above?
Hard to understand
Easy to understand